A Study to Investigate HCV Response Rates in Real World Patients: HEARTLAND Study

Condition:   Chronic Hepatitis C Intervention:   Drug: paritaprevir/ritonavir/ombitasvir + dasabuvir +/- ribavirin Sponsors:   American Research Corporation;   AbbVie Completed

Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials